Loading clinical trials...
Loading clinical trials...
A Prospective Randomised Controlled Trial of the Effect of Magnesium Sulphate Administration on Red Cell Transketolase Activity in Alcohol Dependent Patients at Risk of Wernicke Korsakoff Syndrome Treated With Thiamine
Conditions
Interventions
Magnesium Sulfate
Pabrinex
Locations
1
United Kingdom
Glasgow Royal Infirmary
Glasgow, United Kingdom
Start Date
December 16, 2016
Primary Completion Date
April 2, 2018
Completion Date
June 19, 2018
Last Updated
July 31, 2019
NCT06644534
NCT06173973
NCT06840652
NCT06402123
NCT06727318
NCT03737864
Lead Sponsor
Glasgow Royal Infirmary
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions